Anti-CD20 monoclonal antibodies, low risk of pyoderma gangrenosum

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2025年 / 2043卷 / 1期
关键词：
D O I：
10.1007/s40278-025-75282-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [21] Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: Commentary
    Lycke, Jan
    Svenningsson, Anders
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (08) : 1177 - 1178
  • [22] The role of antigenic modulation in controlling the efficacy of anti-CD20 monoclonal antibodies
    Beers, S. A.
    Chan, C. H. T.
    James, S.
    French, R. R.
    Attfield, K. E.
    Brennand, C. M.
    Ahuja, A.
    Shlomchik, M.
    Cragg, M. S.
    Glennie, M. J.
    IMMUNOLOGY, 2008, 125 : 48 - 49
  • [23] Monoclonal anti-CD20 antibodies: Mechanisms of action and monitoring of biological effects
    Renaudineau, Yves
    Devauchelle-Pensec, Valerie
    Hanrotel, Catherine
    Pers, Jacques-Olivier
    Saraux, Alain
    Youinou, Pierre
    JOINT BONE SPINE, 2009, 76 (05) : 458 - 463
  • [24] Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies
    Okroj, Marcin
    Osterborg, Anders
    Blom, Anna M.
    CANCER TREATMENT REVIEWS, 2013, 39 (06) : 632 - 639
  • [25] The latest developments with anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia
    Evers, Mitchell
    Jak, Margot
    Leusen, J. H. W.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (09) : 973 - 982
  • [26] Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders
    Dierickx, Daan
    Delannoy, Andre
    Saja, Khalid
    Verhoef, Gregor
    Provan, Drew
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (03) : 278 - 291
  • [27] Is there a role for anti-CD20 antibodies in CLL?
    Shah, Harsh R.
    Stephens, Deborah M.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 68 - 75
  • [28] Clinical applications of anti-CD20 antibodies
    Gopal, AK
    Press, OW
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (05): : 445 - 450
  • [29] The mechanism of action of anti-CD20 monoclonal antibodies used in the treatment of multiple sclerosis
    Mycko, Marcin P.
    AKTUALNOSCI NEUROLOGICZNE, 2023, 23 (03): : 72 - 78
  • [30] IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodies
    Grzelak, Ludivine
    Roesch, Ferdinand
    Vaysse, Amaury
    Biton, Anne
    Legendre, Rachel
    Porrot, Francoise
    Commere, Pierre-Henri
    Planchais, Cyril
    Mouquet, Hugo
    Vignuzzi, Marco
    Bruel, Timothee
    Schwartz, Olivier
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 (10) : 1648 - 1661
12345